Could supplements be the next big opportunity in the GLP-1 weight-loss drug boom?
Novonesis is exploring whether gut health supplements could benefit patients taking GLP-1 weight-loss drugs, opening up a potentially lucrative new market
Originally published by CNBC. Summary and curation by DutyStation News.

